- Home
- RYTM vs GDS Comparison
RYTM vs GDS Comparison
Compare RYTM & GDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- GDS
- Stock Information
- Founded
- RYTM 2008
- GDS 2001
- Country
- RYTM United States
- GDS China
- Employees
- RYTM N/A
- GDS N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- GDS Computer Software: Programming Data Processing
- Sector
- RYTM Health Care
- GDS Technology
- Exchange
- RYTM Nasdaq
- GDS Nasdaq
- Market Cap
- RYTM 6.4B
- GDS 7.4B
- IPO Year
- RYTM 2017
- GDS 2016
- Fundamental
- Price
- RYTM $97.86
- GDS $39.66
- Analyst Decision
- RYTM Strong Buy
- GDS Strong Buy
- Analyst Count
- RYTM 13
- GDS 7
- Target Price
- RYTM $109.77
- GDS $47.51
- AVG Volume (30 Days)
- RYTM 627.7K
- GDS 3.9M
- Earning Date
- RYTM 11-04-2025
- GDS 11-18-2025
- Dividend Yield
- RYTM N/A
- GDS N/A
- EPS Growth
- RYTM N/A
- GDS N/A
- EPS
- RYTM N/A
- GDS 3.46
- Revenue
- RYTM $156,287,000.00
- GDS $1,526,241,101.00
- Revenue This Year
- RYTM $46.10
- GDS $13.40
- Revenue Next Year
- RYTM $60.39
- GDS $14.00
- P/E Ratio
- RYTM N/A
- GDS $190.32
- Revenue Growth
- RYTM 53.55
- GDS 10.29
- 52 Week Low
- RYTM $45.91
- GDS $16.93
- 52 Week High
- RYTM $106.52
- GDS $52.50
- Technical
- Relative Strength Index (RSI)
- RYTM 49.11
- GDS 54.96
- Support Level
- RYTM $95.88
- GDS $39.09
- Resistance Level
- RYTM $102.79
- GDS $43.88
- Average True Range (ATR)
- RYTM 3.20
- GDS 2.35
- MACD
- RYTM -0.25
- GDS -0.07
- Stochastic Oscillator
- RYTM 32.99
- GDS 33.95
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About GDS GDS Holdings Limited ADS
GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia via the now 38% owned DayOne. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.